Want to join the conversation?
Based on its 3Q15 results $GILD now expects its FY15 net product sales to be in the range of $30-31Bil at a gross margin of 88-90%; R&D expenses to be between $2.8-3Bil and SG&A expenses to be between $3-3.2Bil; and diluted EPS impact of acquisition-related, restructuring, stock-based compensation expenses and other to be between $0.82-0.87.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?